Mirae Asset Global ETFs Holdings
CSTL icon

Mirae Asset Global ETFs Holdings’s Castle Biosciences CSTL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
13,785
+109
+0.8% +$2.43K ﹤0.01% 2238
2026
Q1 		$336K Buy
13,676
+453
+3% +$14.8K ﹤0.01% 2092
2025
Q4 		$514K Sell
13,223
-50
-0.4% -$1.61K ﹤0.01% 1881
2025
Q3 		$302K Sell
13,273
-2,288
-15% -$46.5K ﹤0.01% 2103
2025
Q2 		$318K Buy
15,561
+120
+0.8% +$2.22K ﹤0.01% 2041
2025
Q1 		$309K Buy
15,441
+655
+4% +$16.2K ﹤0.01% 2099
2024
Q4 		$394K Buy
14,786
+608
+4% +$18.5K ﹤0.01% 2042
2024
Q3 		$404K Buy
14,178
+1,162
+9% +$29.6K ﹤0.01% 2022
2024
Q2 		$283K Buy
+13,016
New +$290K ﹤0.01% 2094

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CSTL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Castle Biosciences (CSTL) stake by 0.8% in Q2 2026, buying an estimated $2.43K and bringing the position to 13,785 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Mirae Asset Global ETFs Holdings first reported a position in CSTL in Q2 2024 and has held it in 9 quarters since. The position peaked at $514K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 13,785 shares of Castle Biosciences worth $329K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 109 Castle Biosciences shares in Q2 2026, an estimated $2.43K.
  • Castle Biosciences made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2238 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Castle Biosciences in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Castle Biosciences position peaked at $514K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.